Researchers optimizing progesterone for brain injury treatment

Oct 19, 2009

As doctors begin to test progesterone for traumatic brain injury at sites across the country, researchers are looking ahead to optimizing the hormone's effectiveness.

Two abstracts summarizing Emory research on are being presented at the 2009 Society for Neuroscience (SFN) meeting in Chicago.

A multisite phase III clinical trial called ProTECT III will begin to evaluate progesterone's effectiveness for treating early next year. The trial grows out of years of research by Donald Stein, PhD, Asa G. Candler Professor of Emergency Medicine at Emory School of Medicine, demonstrating that progesterone can protect damaged . Stein is director of the Department of Emergency Medicine's Brain Research Laboratory.

One of the SFN abstracts reports on progesterone analogues that are more water-soluble. This work comes from Stein and his colleagues in collaboration with the laboratory of Dennis Liotta, PhD, Emory professor of chemistry.

Currently, the lack of water solubility limits delivery of progesterone, in that the hormone must be prepared hours ahead and cannot be kept at room temperature. Small chemical modifications may allow similar compounds with the same effects as progesterone to be given to patients closer to the time of injury.

According to the results, two compounds similar to progesterone showed an equivalent ability to reduce brain swelling in an animal model of traumatic brain injury.

The second abstract describes evidence that adding vitamin D to progesterone enhances the hormone's effectiveness when applied to neurons under stress in the laboratory. Like progesterone, vitamin D is a that is inexpensive, has good safety properties and acts on many different biochemical pathways.

The authors showed that a low amount of vitamin D boosted the ability of progesterone to protect neurons from excito-toxicity , a principal cause of brain injury and .

More information:

• The first research was recently published online by the Journal of Medicinal Chemistry. www.ncbi.nlm.nih.gov/pubmed/19791804
• The vitamin D research was recently published by the journal Molecular Medicine. www.ncbi.nlm.nih.gov/pubmed/19603099

Source: Emory University (news : web)

Explore further: Paralyzed man recovers some function following transplantation of OECs and nerve bridge

add to favorites email to friend print save as pdf

Related Stories

Pill ingredient could prevent brain damage after head injury

Apr 30, 2008

A common component of the contraceptive pill (progesterone) could improve the neurologic outcome for patients with severe head injuries, according to a study published in BioMed Central’s open access journal Critical Ca ...

Study: Progesterone leads to inflammation

Aug 19, 2009

Scientists at Michigan State University have found exposure to the hormone progesterone activates genes that trigger inflammation in the mammary gland.

The abortion pill compound prevents breast tumor growth

Nov 30, 2006

The chemical compound for the abortion pill has been found to prevent the growth of mammary tumors caused by the mutant gene responsible for a majority of breast and ovarian cancers, according to UC Irvine scientists.

Recommended for you

Team untangles the biological effects of blue light

8 hours ago

Blue light can both set the mood and set in motion important biological responses. Researchers at the University of Pennsylvania's School of Medicine and School of Arts and Sciences have teased apart the ...

Mouse model provides new insight in to preeclampsia

9 hours ago

Worldwide, preeclampsia is a leading cause of maternal deaths and preterm births. This serious pregnancy complication results in extremely high blood pressure and organ damage. The onset of preeclampsia is associated with ...

Scientists unravel the mystery of a rare sweating disorder

9 hours ago

An international research team discovered that mutation of a single gene blocks sweat production, a dangerous condition due to an increased risk of hyperthermia, also known as heatstroke. The gene, ITPR2, controls a basic ...

User comments : 0